McKesson Corporation with price, financials, news flow, and insider context in one page.
McKesson Corporation is being tracked here through price action, operating context, and headline flow. This public page covers the latest market move, where MCK sits inside Healthcare and Medical Distribution, and the key financial markers that matter before moving into a fuller research workflow.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
This page is structured for research context, not a trade call. It gives you a clean read on where MCK sits in its range, what the last few quarters look like, and which headlines are shaping attention.
For position sizing, alerts, saved watchlists, and deeper analysis workflows, the next step is the logged-in Meridian workspace.
| Quarter | Revenue | Net income | Free cash flow |
|---|---|---|---|
| Q1 2026 | 96.3B | 1.68B | 3.24B |
| Q4 2025 | 106.16B | 1.19B | 1.06B |
| Q3 2025 | 103.15B | 1.11B | 2.22B |
| Q2 2025 | 97.83B | 784M | -1.11B |
See the next report date, earnings cadence, and reporting context.
Open a side-by-side comparison page to frame valuation and growth.
Read open desk notes tied to sectors, macro themes, and active names.
Learn the framework behind valuation, momentum, and risk before you act.
McKesson Corporation (MCK) — questions investors ask
What is the current stock price of McKesson Corporation (MCK)?
McKesson Corporation (MCK) is trading at $763.51, down 0.04% in the latest session. The live price and one-year chart on this page update through the trading day.
What is McKesson Corporation's market capitalization?
McKesson Corporation has a market capitalization of about 89.39B, derived from the latest share price and shares outstanding.
When is McKesson Corporation's next earnings date?
McKesson Corporation is next expected to report earnings on Aug 5, 2026. The MCK earnings page tracks the estimate and reporting history.
What is McKesson Corporation's P/E ratio?
McKesson Corporation trades at a forward price-to-earnings ratio of 15.17 — one measure of how the market is pricing its future earnings.
What is MCK's 52-week trading range?
Over the past 52 weeks, MCK has traded between $637.00 and $999.00.
What sector is McKesson Corporation in?
McKesson Corporation operates in the Healthcare sector, within the Medical Distribution industry.
Does McKesson Corporation pay a dividend?
McKesson Corporation currently carries a dividend yield of about 43.0%.
What is the analyst price target for MCK?
The mean analyst price target for MCK is $941.40, with an overall analyst view of Strong Buy.
A public stock page should answer the first research questions before asking for a signup.
This MCK page is designed for public research utility. You can read the latest session move, check the one-year chart, review a compact financial table, scan recent headlines, and compare adjacent names without immediately moving into a gated dashboard.
The logged-in Meridian workflow goes further with saved watchlists, deeper analysis, alert routing, and recurring review systems. The public layer is meant to be credible and indexable on its own, not a hollow teaser page.